病理T3a 期肾细胞癌不同侵犯类型与患者预后相关性分析

Association between different invasion subtypes and prognosis in patients with pathological T3a renal cell carcinoma

  • 摘要: 背景 肾细胞癌是泌尿系统常见恶性肿瘤之一,肿瘤分期是预后评估的重要依据,但病理T3a 期肾癌中不同侵犯类型的患者预后存在显著差异。目的 探究病理T3a 期肾细胞癌患者不同侵犯类型及种类对预后差异的影响。方法 回顾性分析2006 年1 月至2024 年12 月在解放军总医院泌尿外科诊治并病理诊断为T3a 期的1 014 例肾细胞癌患者的临床资料。根据病理结果中肿瘤侵犯肾周脂肪、肾窦脂肪、肾静脉及其分支或者集合系统中的一种或多种类型分为单独侵犯组和联合侵犯组,联合侵犯组进一步按侵犯种类的数量分为2 种、3 种和4 种侵犯。比较不同侵犯类型患者的肿瘤特异生存(cancerspecific survival,CSS)、总体生存(overall survival,OS) 和无病生存(disease-free survival,DFS),并明确影响患者预后的独立危险因素。结果 本研究共纳入病理T3a 期肾细胞癌患者1 014 例。其中男性748 例,女性266 例,平均年龄为(57.0±12.1) 岁。其中单独侵犯组患者757 例,包括肾周脂肪侵犯163 例,肾窦脂肪侵犯313 例,肾静脉及其分支侵犯129例,集合系统侵犯152 例;联合侵犯组257 例。与单独侵犯组相比,联合侵犯组年龄更大[(58.5±12.4) 岁 vs (56.6±10.7)岁,P=0.013],肿瘤最大直径更大[(7.39±2.85) cm vs (5.86±3.13) cm,P<0.001],接受根治性肾切除的比例较高(98.1% vs 89.3%,P<0.001),WHO/ISUP 3 ~ 4 级肿瘤所占比例较高(35.2% vs 20.1%,P<0.001)。Kaplan-Meier 生存分析显示,联合侵犯组的CSS、OS和DFS均显著低于单独侵犯组(均P<0.001)。在联合侵犯组中,随着侵犯部位种类的增加,患者3 年CSS (P=0.042)、OS (P=0.048) 和DFS (P<0.001) 呈下降趋势。多因素Cox 回归分析结果显示,在调整年龄、肿瘤大小、病理类型及WHO/ISUP核分级、手术年份等因素后,联合侵犯仍是影响患者CSS和DFS的独立危险因素(CSS:HR=2.228,95% CI:1.506 ~ 3.297,P=0.001;DFS:HR=2.020,95% CI:1.535 ~ 2.660,P<0.001)。结论 病理诊断的T3a 期肾细胞癌患者肿瘤侵犯类型对预后的影响差异无统计学意义,但是联合侵犯及联合侵犯中侵犯种类的数量多提示更差的预后。联合侵犯及侵犯种类的数量可作为病理T3a期肾癌重要的预后评估指标。

     

    Abstract: Background Renal cell carcinoma is one of the most common malignant tumors of the urinary system, and tumor staging is a crucial basis for prognostic assessment. However, significant heterogeneity exists among patients with pathologically staged T3a renal cell carcinoma according to different invasion subtypes. Objective To investigate the prognostic values of different invasion subtypes in patients with pathological T3a renal cell carcinoma (RCC). Methods Clinical data about 1 014 patients with pathological T3a RCC who were treated at the Department of Urology of PLA General Hospital from January 2006 to December 2024 were retrospectively analyzed. According to pathological findings, patients were categorized into an isolated invasion subtype group or a combined invasion subtype group based on tumor invasion into one or more of the following structures: perirenal fat, renal sinus fat, renal vein or its segmental branches, pelvicalyceal system. The combined invasion subtype group was further categorized according to the number of invaded sites into 2, 3, and 4 site invasion subgroups. Cancer-specific survival (CSS), overall survival (OS), and disease-free survival (DFS) were compared among patients with different invasion subtypes, and independent prognostic factors were identified.Results A total of 1 014 patients (748 males, 266 females) with pathological T3a RCC were included in this study, with a mean age of (57.0 ± 12.1) years. Of these, 757 cases were classified into the isolated invasion subtype group, including 163 cases with perirenal fat invasion, 313 cases with renal sinus fat invasion, 129 cases with renal vein or its segmental branches invasion, and 152 cases with pelvicalyceal system invasion, while 257 patients were classified into the combined invasion subtype group. Compared with the isolated invasion subtype group, patients in the combined invasion subtype group were significantly older (58.5 ± 12.4) years vs (56.6 ± 10.7) years, P=0.013, had larger maximum tumor diameters (7.39 ± 2.85) cm vs (5.86 ± 3.13) cm, P<0.001, underwent radical nephrectomy more frequently (98.1% vs 89.3%, P<0.001), showed a higher proportion of WHO/ISUP grade 3 – 4 tumors (35.2% vs 20.1%, P<0.001). Kaplan – Meier survival analysis demonstrated that patients with a combined invasion subtype had significantly worse CSS, OS and DFS than those with an isolated invasion subtype (all P<0.001). Within the combined invasion subtype group, CSS (P=0.042), OS (P=0.048), and DFS (P<0.001) progressively decreased with an increasing number of invaded sites. Multivariate Cox regression analysis showed that combined invasion subtype remained an independent prognostic factor for CSS and DFS after adjustment for age, tumor size, histological subtype, WHO/ISUP nuclear grade and surgery year (CSS: HR=2.228, 95% CI: 1.506 - 3.297, P=0.001; DFS: HR=2.020, 95% CI: 1.535 - 2.660, P<0.001).Conclusion In patients with pathological T3a RCC, no significant prognostic differences are identified among individual invasion subtypes. A combined invasion subtype indicates a poorer prognosis, and both invasion subtype and the number of invaded sites may serve as important prognostic indicators for patients with pathological T3a RCC.

     

/

返回文章
返回